Order byBest matchMost fresh

Trump, tariffs and pharmaceutical industry

Digest more
Top News
Overview
The Washington Post |
President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether drugmakers try to pass on the costs.
BBC |
Donald Trump took to Truth Social to announce even tougher tariffs on China and a 90-day pause on higher tariffs for dozens of countries.

Read more on News Digest

Trump pledges tariffs on pharmaceuticals, setting up fight over who pays
President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether drugmakers try to pass on the costs.
Trump threatens to end pharmaceuticals tariff exemption
The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.
How Trump's Pharmaceutical Tariffs Could Send Drug Prices Soaring
The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.
Trump’s Tariffs: Has He Backed Down?
Trump hikes China tariffs to 125% while cutting others
The Latest: Treasury secretary says Trump will keep 10% import tariff, raise import tax on China
President Donald Trump has shared on Truth Social that he has “authorized a 90 day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately.”
'The Economist' editor unpacks the 'biggest trade policy shock' of Trump's tariffs
President Trump's sweeping tariff policy has upended the global economy. Zanny Minton Beddoes, the editor-in-chief of The Economist, likens it to The Art of the Deal — on steroids.
STAT8d
Pharmaceuticals are spared from tariffs, for now
President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries that his administration sees as engaging in unfair trade. The White House wrote in a fact sheet, though, that pharmaceuticals are exempt from these tariffs.
Conduit Pharmaceuticals announces novel cocrystal patent filing for VTAMA
Conduit Pharmaceuticals (CDT) announces the filing of two groundbreaking patents for tapinarof, VTAMA, including a dual active cocrystal,
Science Daily9d
Pharmaceuticals News
Apr. 1, 2025 — A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and ... Could an Arthritis Drug Unlock ...
Recursion Pharmaceuticals Advances B-Cell Lymphoma Treatment in Phase 1 Trial
Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell lymphoma treatment.
Trump figuring out next steps in global tariff battle
In the aftermath of this week's tariff whiplash, President Donald Trump is deciding exactly what he wants out of trade talks with as many as 75 nations in the coming weeks. Trump is also figuring out next steps with China.
Trump's Tariffs Threaten to End Quarter-Century Era of Cheap Goods for U.S. Consumers
President Donald Trump’s new tariffs threaten to push up prices on clothes, mobile phones, furniture and many other products in the coming months
Feedback